Lisa Vermunt

Featured in: Favicon

nature.com Favicon

alzheimersanddementia.com Favicon

onlinelibrary.wiley.com

Articles

Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles - Nature Aging

Jan 8, 2024 | nature.com | Betty M. Tijms |Henne Holstege |Lisa Vermunt |Niccolò Tesi |Eugeen Vanmechelen |Frederik Barkhof | +1 more

AbstractAlzheimer’s disease (AD) is heterogenous at the molecular level. Understanding this heterogeneity is critical for AD drug development. Here we define AD molecular subtypes using mass spectrometry proteomics in cerebrospinal fluid, based on 1,058 proteins, with different levels in individuals with AD (n = 419) compared to controls (n = 187).

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →